Map
Research results related to the cultivation technology of GAIA-102 received the Excellent Presentation Award at the 23rd Congress of the Japanese Society for Regenerative Medicine
Fukuoka, JAPAN – At the 23rd Congress of the Japanese Society for Regenerative Medicine, research results related to the cultivation technology aimed at improving the productivity of GAIA-102, conducted at Department of Innovative Biomedicine for Drug Discovery at Graduate School of Pharmaceutical Sciences, Kyushu University (Principal research scientist Professor Yoshi Yonemitsu) received the Excellent Presentation Award. This research results are expected to significantly contribute to the mass production of GAIA-102.
Summary of the presentation:
Title: Enhancing GAIA-102 expansion: using 4-1BB agonist and IL-21 to proliferate NK-like cells from PBMCs
Author: Shuyue Yuan
Session Theme: Bone marrow/Blood 1
Session: Poster 28-5
About GAIA-102:
GAIA-102 is a unique NK-like cell with high cytotoxic activity for various intractable solid tumors. Clinical trials are underway targeting non-small cell lung cancer (NSCLC), advanced Gastrointestinal Cancers (Gastric Cancer/Pancreatic Cancer) of Microsatellite Stable (MSS) and refractory/relapsed pediatric solid tumors.
https://www.congre.co.jp/jsrm2024/dl/award_list.pdf
